{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"glutaminase-deficiency","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Glutaminase deficiency is characterized by refractory seizures, respiratory failure, brain abnormalities and death in the neonatal period, though milder cases with spastic ataxia-dysarthria have also been reported. This condition is caused by mutations in the glutaminase (GLS) gene.","mondoId":"MONDO:0600001","node":{"canonicalSlug":"glutaminase-deficiency","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"glutaminase deficiency","paragraphs":["Glutaminase deficiency is characterized by refractory seizures, respiratory failure, brain abnormalities and death in the neonatal period, though milder cases with spastic ataxia-dysarthria have also been reported. This condition is caused by mutations in the glutaminase (GLS) gene."],"scope":"exact","source":"MONDO","upstream":"PMID:30575854, PMID:30970188","url":"https://monarchinitiative.org/MONDO:0600001"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"disorder of glutamine metabolism","mondoId":"MONDO:0017352","slug":"disorder-of-glutamine-metabolism"},{"kind":"child","label":"developmental and epileptic encephalopathy, 71","mondoId":"MONDO:0032678","slug":"developmental-and-epileptic-encephalopathy-71"},{"kind":"child","label":"spastic ataxia-dysarthria due to glutaminase deficiency","mondoId":"MONDO:0034146","slug":"spastic-ataxia-dysarthria-due-to-glutaminase-deficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/26291"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0600001\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>PMID:30575854, PMID:30970188</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Glutaminase deficiency is characterized by refractory seizures, respiratory failure, brain abnormalities and death in the neonatal period, though milder cases with spastic ataxia-dysarthria have also been reported. This condition is caused by mutations in the glutaminase (GLS) gene.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0600001\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"glutaminase-deficiency","sourceDocuments":[{"name":"MONDO: glutaminase deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0600001"}],"sourceNote":"","synonyms":["glutaminase deficiency"],"takeawayHtml":"","title":"glutaminase deficiency"},"schemaVersion":1}
